Topic

Cigna

A collection of 1335 issues

Get Xospata (Gilteritinib) Approved by Cigna in Washington: Prior Authorization, Appeals & Alternatives

Answer Box: Getting Xospata (Gilteritinib) Covered by Cigna in Washington Eligibility: Xospata requires prior authorization from Cigna for adults with relapsed/refractory AML who have FLT3-mutated disease confirmed by an FDA-approved test. Fastest path: Have your hematologist submit clinical documentation showing FLT3 mutation positivity, prior therapy failures, and medical necessity

The Requirements Checklist to Get Elfabrio (pegunigalsidase alfa-iwxj) Covered by Cigna in Virginia

Answer Box: Getting Elfabrio Covered by Cigna in Virginia Eligibility: Adults with confirmed Fabry disease (genetic testing or enzyme deficiency) can get Elfabrio covered by Cigna without step therapy as of March 2024. Fastest path: Submit complete prior authorization with ICD-10 code E75.21, HCPCS J0219, specialist prescription, and genetic/

How to Get Advate (octocog alfa) Covered by Cigna in California: Complete PA Forms, Appeals & Contact Guide

Answer Box: Getting Advate (octocog alfa) Covered by Cigna in California Fast Track to Approval: Cigna requires prior authorization for Advate (octocog alfa) in California. Your hematologist must submit Form 61-211 with clinical documentation to 800-390-9745. Standard review takes 72 hours; expedited takes 24 hours for urgent cases. If denied,

How to Get Prolastin-C Covered by Cigna in Virginia: Complete Prior Authorization Guide

Answer Box: Getting Prolastin-C Covered by Cigna in Virginia Prolastin-C requires prior authorization from Cigna in Virginia. To get approved, you need: (1) documented alpha1-antitrypsin deficiency with severe genotype (Pi*ZZ), (2) AAT serum level <11 mcmol/L, and (3) lung function evidence (FEV1 <65% predicted or accelerated

Getting Brineura (Cerliponase Alfa) Covered by Cigna in New York: Complete PA Guide and Appeals Process

Answer Box: Getting Started Today To get Brineura (cerliponase alfa) covered by Cigna in New York, you need: 1) Confirmed CLN2 diagnosis with genetic/enzyme testing, 2) Prescription from a pediatric neurologist or specialist, and 3) Prior authorization through Cigna's specialty pharmacy (Express Scripts/Accredo). Start by gathering

How to Get Stelara (Ustekinumab) Covered by Cigna in Pennsylvania: Coding, Appeals, and Step Therapy Guide

Answer Box: Getting Stelara Covered by Cigna in Pennsylvania Fastest path to approval: Complete Cigna's prior authorization form with proper ICD-10 codes (L40.0 for plaque psoriasis, K50.x for Crohn's), document step therapy failures, and include specialist notes showing medical necessity. If denied, Pennsylvania'

Getting Daybue (Trofinetide) Covered by Cigna in New York: Prior Authorization, Appeals, and Cost Assistance

Answer Box: Fastest Path to Daybue Coverage with Cigna in New York Daybue (trofinetide) requires prior authorization from Cigna and must be dispensed through a designated specialty pharmacy. To get coverage: 1. Submit PA request with confirmed Rett syndrome diagnosis, patient age ≥2 years, and specialist attestation 2. Use Cigna&

How to Get Fabrazyme (Agalsidase Beta) Covered by Cigna in New Jersey: Complete Prior Authorization and Appeals Guide

Quick Answer: Fabrazyme requires prior authorization with Cigna in New Jersey. Submit genetic/biochemical confirmation of Fabry disease, specialist documentation, and medical necessity letter via CoverMyMeds or Cigna portal. Standard review takes 5 business days. If denied, appeal through Cigna's internal process, then New Jersey's IHCAP

Renewing Kymriah (tisagenlecleucel) Approval with Cigna in Ohio: Complete 2024 Guide to Annual Reauthorization

Answer Box: Kymriah Annual Renewal with Cigna in Ohio Cigna requires annual reauthorization for Kymriah (tisagenlecleucel) through their Gene Therapy Program. Start your renewal 60-90 days before your current approval expires. Submit updated clinical documentation showing continued medical necessity, response to treatment, and compliance with monitoring requirements through Cigna'

How to Get Nucala (Mepolizumab) Covered by Cigna in Michigan: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Nucala Covered by Cigna in Michigan Cigna requires prior authorization for Nucala (mepolizumab) in Michigan with specific eosinophil count criteria (≥300 cells/µL) and step therapy requirements. You'll likely need to try benralizumab or dupilumab first unless contraindicated. If denied, Michigan's DIFS external